🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicenter, randomized, double-blind, placebo-controlled, phase II study...
Status
Completed
Location
First Hospital of Hebei Medical University
Start Date
2022-11-24
Trial ID
NCT05769946
Treatments Being Tested
This is a phase 2, multi-center, randomized, placebo-controlled, double-bli...
Status
Terminated
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-11-30
Trial ID
NCT04609397
This is a phase 3, multi-center, randomized, placebo-controlled, double-bli...
Status
Recruiting
Location
Beijing Friendship hospital capital medical hospital
Start Date
2023-11-13
Trial ID
NCT06145893
The purpose of this study was to evaluate the pharmacokinetics of Hemay 005...
Status
Recruiting
Location
Union Hospital of Tongji Medical College; Huazhong University of Science and Technology
Start Date
2024-04-28
Trial ID
NCT06376474
Treatments Being Tested
Explore the influence of different administration methods (titration/non-ti...
Status
Completed
Location
The Second Affiliated Hospital of Wannan Medical College
Start Date
2024-12-25
Trial ID
NCT06908642
Treatments Being Tested
1. To evaluate the pharmacokinetics of Hemay005 tablets on midazolam and it...
Status
Completed
Location
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-12-12
Trial ID
NCT06610890
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled p...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2022-08-05
Trial ID
NCT05407246
Treatments Being Tested
The aim of this study was to evaluate the pharmacokinetics of Hemay005 tabl...
Status
Completed
Location
Union Hospital of Tongji Medical College; Huazhong University of Science and Technology
Start Date
2024-05-07
Trial ID
NCT06380153
Treatments Being Tested
Hemay005 is a novel phosphodiesterase type 4(PDE4) inhibitor being develope...
Status
Completed
Location
Peking University People's Hospital
Start Date
2022-01-20
Trial ID
NCT04839328
Treatments Being Tested
The purpose of this phase III, multicenter, double-blind, placebo-controlle...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital,Sun Yat-Sen University
Start Date
2026-06
Trial ID
NCT07650942
Treatments Being Tested